Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biocryst Pharmaceuticals

8.96
+0.20002.28%
Pre-market: 8.980.0200+0.22%08:13 EDT
Volume:3.32M
Turnover:29.63M
Market Cap:1.87B
PE:-34.53
High:8.98
Open:8.78
Low:8.75
Close:8.76
Loading ...
May 04, 2020

Correspondence

CORRESP [Cover] - Correspondence
Apr 17, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Apr 10, 2020

Major Issues Report

8-K - Current report
Apr 02, 2020

Major Issues Report

Current report, items 5.02, 7.01, and 9.01
Mar 30, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Mar 13, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2020

Major Issues Report

Current report, item 1.02
Mar 05, 2020

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Mar 05, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 25, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Feb 18, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 03, 2020

Major Issues Report

Current report, items 8.01 and 9.01